Scientists find neurological link to Type II diabetes

Image
Press Trust of India New Delhi
Last Updated : Jan 21 2013 | 5:46 PM IST

A team of Indian scientists have discovered a neurological link to Type II diabetes (T2D), a finding that could open new pathways for treatment of the ailment, traditionally linked to rise in level of blood sugar.

In doing so, 37 scientists led by Dwaipayan Bhardwaj of CSIR-Institute of Genomics and Integretive Biology (IGIB) and Nikhil Tandon of AIIMS also achieved a first of sorts when the research team studied two ethnic populations including Indo-Europeans and Dravidians to understand more about diabetes.

"We have identified a new locus associated with T2D ... The genes TMEM163, RAB3GAP1 and ACMSDI... Are involved in neurologic processes, suggesting a neurologic component in the etiology of T2D," said the scientists reporting their findings in 'Diabetes' journal of the American Diabetes Association.

"This is also the first and the largest 'Genome Wide Association Study' (GWAS) conducted for any complex disorder conceived and executed entirely in the developing world," Samir K Brahmachari, Director General of the Council of Industrial and Scientific Research (CSIR) told reporters here.

The study has identified a new dimension to T2D and could open up new pathways for better understanding of the complex ailment.

"The finding could also lead to new line of targeted therauptics," Tandon said.

"This study shall go a long way in furthering the aims and objectives of INDICO consortium as well as untangling the intricacies involved in this complex disorder," Bharadwaj said.

Further work on functionally validating this genomic discovery has already been initiated by Bharadwaj's group, at the well-established facility at CSIR-IGIB through the development of zebra fish models.

The INDICO consortium attracts countrywide participation spanning Delhi, Lucknow, Chandigarh, Jaipur and Chennai, involving premier research institutes and stalwarts of diabetes research like Tandon.

Since Indians are not only genetically diverse but also have an exceptionally high prevalence of type 2 diabetes, the consortium provides researchers a unique and unparalleled opportunity to investigate the complex dimensions of diabetes genetics.

The work involved 12,535 Indians, with an initial phase involving 2,465 subjects, type 2 Diabetes patients and matched individuals in the research, followed by validation in two ethnic populations of India including Indo-Europeans and Dravidians, and a comprehensive meta-analysis comparing the studies.

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 12 2012 | 5:05 PM IST

Next Story